United Therapeutics Corp’s recent filing unveils that its Chairperson & CEO ROTHBLATT MARTINE A unloaded Company’s shares for reported $1.8 million on Oct 06 ’25. In the deal valued at $449.69 per share,4,000 shares were sold. As a result of this transaction, ROTHBLATT MARTINE A now holds 130 shares worth roughly $58926.399999999994.
Then, ROTHBLATT MARTINE A sold 4,000 shares, generating $1,784,847 in total proceeds. Upon selling the shares at $446.21, the Chairperson & CEO now owns 130 shares.
Before that, ROTHBLATT MARTINE A bought 4,000 shares. United Therapeutics Corp shares valued at $1,798,765 were divested by the FOUNDER, CHAIRPERSON, AND CHIE at a price of $449.69 per share.
RBC Capital Mkts initiated its United Therapeutics Corp [UTHR] rating to an Outperform in a research note published on September 26, 2025; the price target was $569. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in early June with a ‘”an Overweight”‘ rating. Wells Fargo also remained covering UTHR and has decreased its forecast on April 25, 2025 with a “an Equal weight” recommendation from previously “an Overweight” rating. BofA Securities revised its rating on April 21, 2025. It rated UTHR as “a Neutral” which previously was an “an Underperform”.
Price Performance Review of UTHR
On Monday, United Therapeutics Corp [NASDAQ:UTHR] saw its stock jump 0.05% to $453.28. Over the last five days, the stock has gained 6.83%. United Therapeutics Corp shares have risen nearly 28.60% since the year began. Nevertheless, the stocks have risen 28.47% over the past one year. While a 52-week high of $455.12 was reached on 10/06/25, a 52-week low of $266.98 was recorded on 04/09/25.
Levels Of Support And Resistance For UTHR Stock
The 24-hour chart illustrates a support level at 447.26, which if violated will result in even more drops to 441.24. On the upside, there is a resistance level at 457.28. A further resistance level may holdings at 461.28.
How much short interest is there in United Therapeutics Corp?
A steep rise in short interest was recorded in United Therapeutics Corp stocks on 2025-09-15, dropping by 71212.0 shares to a total of 2.78 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 2.86 million shares. There was a decline of -2.56%, which implies that there is a negative sentiment for the stock.
